Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 61 5
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Apr/16/2021 24 7
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 20 10
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Tenofovir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 3 3